The role of MicroRNAs in cardiac stem cells

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Purvis, Nima ^a   Bahn, Andrew ^a   Katare, Rajesh ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 4; MICRORNA; MICRORNA 1; MICRORNA 132; MICRORNA 133; MICRORNA 155; MICRORNA 17; MICRORNA 18; MICRORNA 19A; MICRORNA 19B; MICRORNA 204; MICRORNA 20A; MICRORNA 221; MICRORNA 222; MICRORNA 499; MICRORNA 669A; MICRORNA 669Q; MICRORNA 92A; NOTCH RECEPTOR; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CELL VIABILITY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE THERAPY; HEART ARRHYTHMIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; UPREGULATION; VASCULAR REMODELING;

EID: 84937231252     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/194894     Document Type: Review

References (98)

1. E. A. McCulloch and J. E. Till, "Perspectives on the properties of stem cells, " Nature Medicine, vol. 11, no. 10, pp. 1026-1028, 2005.
2. R. Katare, A. Oikawa, D. Cesselli et al., "Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes, " Cardiovascular Research, vol. 97, no. 1, pp. 55-65, 2013.
3. S. Amadesi, C. Reni, R. Katare et al., "Role for substance P-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects, " Circulation, vol. 125, no. 14, pp. 1774-1786, 2012.
4. R. Katare, F. Riu, K. Mitchell et al., "Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132, " Circulation Research, vol. 109, no. 8, pp. 894-906, 2011.
5. R. Bolli, X.-L. Tang, S. K. Sanganalmath et al., "Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy, " Circulation, vol. 128, no. 2, pp. 122-131, 2013.
6. A. R. Williams, K. E. Hatzistergos, B. Addicott et al., "Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function afer myocardial infarction, " Circulation, vol. 127, no. 2, pp. 213-223, 2013.
7. F. G. P. Welt, R. Gallegos, J. Connell et al., "Effect of cardiac stem cells on lef-ventricular remodeling in a canine model of chronic myocardial infarction, " Circulation: Heart Failure, vol. 6, no. 1, pp. 99-106, 2013.
8. A. Leri, "Human cardiac stem cells: the heart of a truth, " Circulation, vol. 120, no. 25, pp. 2515-2518, 2009.
9. R. Katare, A. Caporali, C. Emanueli, and P. Madeddu, "Ben-fotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response, " Journal of Molecular and Cellular Cardiology, vol. 49, no. 4, pp. 625-638, 2010.
10. R. Katare, A. Caporali, L. Zentilin et al., "Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling, " Circulation Research, vol. 108, no. 10, pp. 1238-1251, 2011.
11. R. G. Katare, A. Caporali, A. Oikawa, M. Meloni, C. Emanuel, and P. Madeddu, "Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway, " Circulation: Heart Failure, vol. 3, no. 2, pp. 294-305, 2010.
12. K. Urbanek, D. Torella, F. Sheikh et al., "Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 24, pp. 8692-8697, 2005.
13. N. Smart, K. N. Dube, and P. R. Riley, "Epicardial progenitor cells in cardiac regeneration and neovascularisation, " Vascular Pharmacology, vol. 58, no. 3, pp. 164-173, 2013.
14. A. Linke, P. Müller, D. Nurzynska et al., "Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 25, pp. 8966-8971, 2005.
15. A. P. Beltrami, L. Barlucchi, D. Torella et al., "Adult cardiac stem cells are multipotent and support myocardial regeneration, " Cell, vol. 114, no. 6, pp. 763-776, 2003.
16. S. Scobioala, R. Klocke, M. Kuhlmann et al., "Up-regulation of nestin in the infarcted myocardium potentially indicates differentiation of resident cardiac stem cells into various lineages including cardiomyocytes, " The FASEB Journal, vol. 22, no. 4, pp. 1021-1031, 2008.
17. M.-J. Goumans, T. P. de Boer, A. M. Smits et al., "TGF-1 induces efcient diferentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro, " Stem Cell Research, vol. 1, no. 2, pp. 138-149, 2008.
18. P. Anversa, J. Kajstura, A. Leri, and R. Bolli, "Life and death of cardiac stem cells: a paradigm shif in cardiac biology, " Circulation, vol. 113, no. 11, pp. 1451-1463, 2006.
19. K. A. Jackson, S. M. Majka, H. Wang et al., "Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells, " Journal of Clinical Investigation, vol. 107, no. 11, pp. 1395-1402, 2001.
20. B. Dawn, A. B. Stein, K. Urbanek et al., "Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3766-3771, 2005.
21. B. Nadal-Ginard, G. M. Ellison, and D. Torella, "The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult, " Stem Cell Research, vol. 13, pp. 615-630, 2014.
22. F. Quaini, K. Urbanek, A. P. Beltrami et al., "Chimerism of the transplanted heart, " The New England Journal of Medicine, vol. 346, no. 1, pp. 5-15, 2002.
23. A. M. Smits, P. van Vliet, C. H. Metz et al., "Human car-diomyocyte progenitor cells diferentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology, " Nature Protocols, vol. 4, no. 2, pp. 232-243, 2009.
24. E. Messina, L. De Angelis, G. Frati et al., "Isolation and expansion of adult cardiac stem cells from human and murine heart, " Circulation Research, vol. 95, no. 9, pp. 911-921, 2004.
25. M. E. Rawles, "The heart-forming areas of the early chick blastoderm, " Physiological Zoology, vol. 16, no. 1, pp. 22-43, 1943.
26. C. Bearzi, M. Rota, T. Hosoda et al., "Human cardiac stem cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14068-14073, 2007.
27. R. M. Seaberg and D. van der Kooy, "Stem and progenitor cells: the premature desertion of rigorous defnitions, " Trends in Neurosciences, vol. 26, no. 3, pp. 125-131, 2003.
28. K. Matsuura, T. Nagai, N. Nishigaki et al., "Adult cardiac Sca-1-positive cells diferentiate into beating cardiomyocytes, " Journal of Biological Chemistry, vol. 279, pp. 11384-11391, 2014.
29. H. Oh, S. B. Bradfute, T. D. Gallardo et al., "Cardiac progenitor cells from adult myocardium: homing, diferentiation, and fusion afer infarction, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12313-12318, 2003.
30. M. Valente, D. S. Nascimento, A. Cumano, and P.-d.-Ó. Perpetua, "Pinto-do OP: Sca-1+ cardiac progenitor cells and heart-making: a critical synopsis, " Stem Cells and Development, vol. 23, no. 19, pp. 2263-2273, 2014.
31. S. Ryzhov, A. E. Goldstein, S. V. Novitskiy, M. R. Blackburn, I. Biaggioni, and I. Feoktistov, "Role of A 2B adenosine receptors in regulation of paracrine functions of stem cell antigen 1-positive cardiac stromal cells, " Journal of Pharmacology and Experimental Terapeutics, vol. 341, no. 3, pp. 764-774, 2012.
32. D. Dey, L. Han, M. Bauer et al., "Dissecting the molecular relationship among various cardiogenic progenitor cells, " Circulation Research, vol. 112, no. 9, pp. 1253-1262, 2013.
33. G. M. Ellison, C. Vicinanza, A. J. Smith et al., "Adult c-kit cardiac stem cells are necessary and sufcient for functional cardiac regeneration and repair, " Cell, vol. 154, no. 4, pp. 827-842, 2013.
34. J. Q. He, D. M. Vu, G. Hunt, A. Chugh, A. Bhatnagar, and R. Bolli, "Human cardiac stem cells isolated from atrial appendages stably express c-kit, " PLoS ONE, vol. 6, no. 11, Article ID e27719, 2011.
35. S. H. Choi, S. Y. Jung, W. Suh, S. H. Baek, and S.-M. Kwon, "Establishment of isolation and expansion protocols for human cardiac C-kit-positive progenitor cells for stem cell therapy, " Transplantation Proceedings, vol. 45, no. 1, pp. 420-426, 2013.
36. T. Hosoda, "C-kit-positive cardiac stem cells and myocardial regeneration, " American Journal of Cardiovascular Disease, vol. 2, pp. 58-67, 2012.
37. A. R. Chugh, G. M. Beache, J. H. Loughran et al., "Administration of cardiac stem cells in patients with ischemic cardiomy-opathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance, " Circulation, vol. 126, no. 11, pp. S54-S64, 2012.
38. J. H. van Berlo, O. Kanisicak, M. Maillet et al., "c-Kit+ cells minimally contribute cardiomyocytes to the heart, " Nature, vol. 509, no. 7500, pp. 337-341, 2014.
39. P. Pandur, I. O. Sirbu, S. J. Kühl, M. Philipp, and M. Kühl, "Islet1-expressing cardiac progenitor cells: a comparison across species, " Development Genes and Evolution, vol. 223, no. 1-2, pp. 117-129, 2013.
40. A. Barzelay, E. Hochhauser, M. Entin-Meer et al., "Islet-1 gene delivery improves myocardial performance afer experimental infarction, " Atherosclerosis, vol. 223, no. 2, pp. 284-290, 2012.
41. L. Bu, X. Jiang, S. Martin-Puig et al., "Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages, " Nature, vol. 460, no. 7251, pp. 113-117, 2009.
42. R. Bolli, A. R. Chugh, D. D'Amario et al., "Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial, " The Lancet, vol. 378, no. 9806, pp. 1847-1857, 2011.
43. R. R. Makkar, R. R. Smith, K. Cheng et al., "Intracoronary cardiosphere-derived cells for heart regeneration afer myocar-dial infarction (CADUCEUS): a prospective, randomised phase 1 trial, " The Lancet, vol. 379, no. 9819, pp. 895-904, 2012.
44. S. A. J. Chamuleau, K. R. Vrijsen, D. G. Rokosh, X. L. Tang, J. J. Piek, and R. Bolli, "Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells, " Netherlands Heart Journal, vol. 17, no. 5, pp. 199-207, 2009.
45. K. U. Hong, Y. Guo, Q. H. Li et al., "c-kit+ cardiac stem cells alleviate post-myocardial infarction lef ventricular dysfunction despite poor engrafment and negligible retention in the recipient heart, " PLoS ONE, vol. 9, no. 5, Article ID e96725, 2014.
46. K. G. Oldroyd, C. Berry, and J. Bartunek, "Myocardial repair and regeneration: bone marrow or cardiac stem cells?" Molecular Terapy, vol. 20, no. 6, pp. 1102-1105, 2012.
47. F. Mouquet, O. Pfster, M. Jain et al., "Restoration of cardiac progenitor cells afer myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells, " Circulation Research, vol. 97, no. 11, pp. 1090-1092, 2005.
48. S. X. Liang and W. D. Phillips, "Migration of resident cardiac stem cells in myocardial infarction, " Anatomical Record, vol. 296, no. 2, pp. 184-191, 2013.
49. R. G. Katare and P. Madeddu, "Pericytes from human veins for treatment of myocardial ischemia, " Trends in Cardiovascular Medicine, vol. 23, no. 3, pp. 66-70, 2013.
50. M. Gnecchi, Z. Zhang, A. Ni, and V. J. Dzau, "Paracrine mechanisms in adult stem cell signaling and therapy, " Circulation Research, vol. 103, no. 11, pp. 1204-1219, 2008.
51. M. Gnecchi, H. He, O. D. Liang et al., "Paracrine action accounts for marked protection of ischemic heart by Akt-modifed mesenchymal stem cells, " Nature Medicine, vol. 11, no. 4, pp. 367-368, 2005.
52. L. Timmers, S. K. Lim, F. Arslan et al., "Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium, " Stem Cell Research, vol. 1, no. 2, pp. 129-137, 2008.
53. J. P. G. Sluijter, V. Verhage, J. C. Deddens, F. Van Den Akker, and P. A. Doevendans, "Microvesicles and exosomes for intracardiac communication, " Cardiovascular Research, vol. 102, no. 2, pp. 302-311, 2014.
54. S. Windmolders, A. De Boeck, R. Koninckx et al., "Mesenchy-mal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident Cardiac Atrial appendage Stem Cells, " Journal of Molecular and Cellular Cardiology, vol. 66, pp. 177-188, 2014.
55. C. Huang, H. Gu, Q. Yu, M. C. Manukyan, J. A. Poynter, and M. Wang, "Sca-1+ cardiac stem cells mediate acute car-dioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion, " PLoS ONE, vol. 6, no. 12, Article ID e29246, 2011.
56. L. Chen, Y. Wang, Y. Pan et al., "Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury, " Biochemical and Biophysical Research Communications, vol. 431, no. 3, pp. 566-571, 2013.
57. V. K. Gangaraju and H. Lin, "MicroRNAs: key regulators of stem cells, " Nature Reviews Molecular Cell Biology, vol. 10, no. 2, pp. 116-125, 2009.
58. K. N. Ivey, A. Muth, J. Arnold et al., "MicroRNA regulation of cell lineages in mouse and human embryonic stem cells, " Cell Stem Cell, vol. 2, no. 3, pp. 219-229, 2008.
59. M. Count, 2013, http://www.mirbase.org/.
60. R. C. Friedman, K. K.-H. Farh, C. B. Burge, and D. P. Bartel, "Most mammalian mRNAs are conserved targets of microR-NAs, " Genome Research, vol. 19, no. 1, pp. 92-105, 2009.
61. S. Rawal, P. Manning, and R. Katare, "Cardiovascular microR-NAs: as modulators and diagnostic biomarkers of diabetic heart disease, " Cardiovascular Diabetology, vol. 13, no. 1, article 44, 2014.
62. J. Han, Y. Lee, K.-H. Yeom et al., "Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex, " Cell, vol. 125, no. 5, pp. 887-901, 2006.
63. J. G. Ruby, C. H. Jan, and D. P. Bartel, "Intronic microRNA precursors that bypass Drosha processing, " Nature, vol. 448, no. 7149, pp. 83-86, 2007.
64. J. Winter, S. Jung, S. Keller, R. I. Gregory, and S. Diederichs, "Many roads to maturity: MicroRNA biogenesis pathways and their regulation, " Nature Cell Biology, vol. 11, no. 3, pp. 228-234, 2009.
65. T. Takaya, K. Ono, T. Kawamura et al., "MicroRNA-1 and microRNA-133 in spontaneous myocardial diferentiation of mouse embryonic stem cells, " Circulation Journal, vol. 73, no. 8, pp. 1492-1497, 2009.
66. Y. Zhao, E. Samal, and D. Srivastava, "Serum response factor regulates a muscle-specifc microRNA that targets Hand2 during cardiogenesis, " Nature, vol. 436, no. 7048, pp. 214-220, 2005.
67. A. Carè, D. Catalucci, F. Felicetti et al., "MicroRNA-133 controls cardiac hypertrophy, " Nature Medicine, vol. 13, no. 5, pp. 613-618, 2007.
68. J. P. G. Sluijter, A. van Mil, P. van Vliet et al., "MicroRNA-1 and-499 regulate diferentiation and proliferation in human-derived cardiomyocyte progenitor cells, " Arteriosclerosis, Trombosis, and Vascular Biology, vol. 30, no. 4, pp. 859-868, 2010.
69. C. Kwon, Z. Han, E. N. Olson, and D. Srivastava, "MicroRNA1 influences cardiac diferentiation in Drosophila and regulates Notch signaling, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 52, pp. 18986-18991, 2005.
70. M. Nemir, A. Croquelois, T. Pedrazzini, and F. Radtke, "Induction of cardiogenesis in embryonic stem cells via downregula-tion of Notch1 signaling, " Circulation Research, vol. 98, no. 12, pp. 1471-1478, 2006.
71. J. Xiao, D. Liang, H. Zhang et al., "MicroRNA-204 is required for diferentiation of human-derived cardiomyocyte progenitor cells, " Journal of Molecular and Cellular Cardiology, vol. 53, no. 6, pp. 751-759, 2012.
72. S. Crippa, M. Cassano, G. Messina et al., "miR669a and miR669q prevent skeletal muscle diferentiation in postnatal cardiac progenitors, " The Journal of Cell Biology, vol. 193, no. 7, pp. 1197-1212, 2011.
73. Y.-K. Kim, J. Yu, T. S. Han et al., "Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer, " Nucleic Acids Research, vol. 37, no. 5, pp. 1672-1681, 2009.
74. P. Sirish, J. E. Lopez, N. Li et al., "MicroRNA profling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts, " Journal of Molecular and Cellular Cardiology, vol. 52, no. 1, pp. 264-272, 2012.
75. J. Wang, S. B. Greene, M. Bonilla-Claudio et al., "Bmp signaling regulates myocardial diferentiation from cardiac progenitors through a MicroRNA-mediated mechanism, " Developmental Cell, vol. 19, no. 6, pp. 903-912, 2010.
76. A. Frustaci, J. Kajstura, C. Chimenti et al., "Myocardial cell death in human diabetes, " Circulation Research, vol. 87, no. 12, pp. 1123-1132, 2000.
77. A. van Mil, K. R. Vrijsen, M.-J. Goumans, C. H. Metz, P. A. Doevendans, and J. P. Sluijter, "MicroRNA-1 enhances the angiogenic diferentiation of human cardiomyocyte progenitor cells, " Journal of Molecular Medicine, vol. 91, no. 8, pp. 1001-1012, 2013.
78. S. Anand, B. K. Majeti, L. M. Acevedo et al., "MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis, " Nature Medicine, vol. 16, no. 8, pp. 909-914, 2010.
79. S. Anand, "A brief primer on microRNAs and their roles in angiogenesis, " Vascular Cell, vol. 5, no. 1, article 2, 2013.
80. G. H. Gibbons and V. J. Dzau, "The emerging concept of vascular remodeling, " The New England Journal of Medicine, vol. 330, no. 20, pp. 1431-1438, 1994.
81. S. Albinsson, Y. Suarez, A. Skoura, S. Ofermanns, J. M. Miano, and W. C. Sessa, "MicroRNAs are necessary for vascular smooth muscle growth, diferentiation, and function, " Arteriosclerosis, Trombosis, and Vascular Biology, vol. 30, no. 6, pp. 1118-1126, 2010.
82. C. Urbich, A. Kuehbacher, and S. Dimmeler, "Role of microRNAs in vascular diseases, infammation, and angiogen-esis, " Cardiovascular Research, vol. 79, no. 4, pp. 581-588, 2008.
83. N. Felli, L. Fontana, E. Pelosi et al., "MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 18081-18086, 2005.
84. A. Aicher, C. Heeschen, C. Mildner-Rihm et al., "Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells, " Nature Medicine, vol. 9, no. 11, pp. 1370-1376, 2003.
85. Y. Li, Y.-H. Song, F. Li, T. Yang, Y. W. Lu, and Y.-J. Geng, "microRNA-221 regulates high glucose-induced endothelial dysfunction, " Biochemical and Biophysical Research Communications, vol. 381, no. 1, pp. 81-83, 2009.
86. B. M. Herrera, H. E. Lockstone, J. M. Taylor et al., "Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes, " Diabetologia, vol. 53, no. 6, pp. 1099-1109, 2010.
87. S. Hu, M. Huang, P. K. Nguyen et al., "Novel microRNA prosurvival cocktail for improving engrafment and function of cardiac progenitor cell transplantation, " Circulation, vol. 124, pp. S27-S34, 2011.
88. S. Roush and F. J. Slack, "The let-7 family of microRNAs, " Trends in Cell Biology, vol. 18, no. 10, pp. 505-516, 2008.
89. J. Liu, A. van Mil, K. Vrijsen et al., "MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1, " Journal of Cellular and Molecular Medicine, vol. 15, no. 7, pp. 1474-1482, 2011.
90. A. Moore, A. Shindikar, I. Fomison-Nurse et al., "Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1, " Cardiovascular Dia-betology, vol. 13, article 68, 2014.
91. Y. Li, C.-M. Yang, Y. Xi et al., "MicroRNA-1/133 targeted dysfunction of potassium channels KCNE1 and KCNQ1 in human cardiac progenitor cells with simulated hyperglycemia, " International Journal of Cardiology, vol. 167, no. 3, pp. 1076-1078, 2013.
92. B. Yang, H. Lin, J. Xiao et al., "The muscle-specifc microRNA MIR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2, " Nature Medicine, vol. 13, no. 4, pp. 486-491, 2007.
93. X. Shi-Wen, A. Leask, and D. Abraham, "Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fbrosis, " Cytokine and Growth Factor Reviews, vol. 19, no. 2, pp. 133-144, 2008.
94. M. S. Ahmed, J. Gravning, V. N. Martinov et al., "Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 4, pp. H1291-H1302, 2011.
95. A. M. Babic, C. C. Chen, and L. F. Lau, "Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo, " Molecular and Cellular Biology, vol. 19, pp. 2958-2966, 1999.
96. S. W. Kim, H. W. Kim, W. Huang et al., "Cardiac stem cells with electrical stimulation improve ischaemic heart function through regulation of connective tissue growth factor and miR-378, " Cardiovascular Research, vol. 100, no. 2, pp. 241-251, 2013.
97. T. Hosoda, H. Zheng, M. Cabral-Da-Silva et al., "Human cardiac stem cell diferentiation is regulated by a mircrine mechanism, " Circulation, vol. 123, no. 12, pp. 1287-1296, 2011.
98. A. Izarra, I. Moscoso, E. Levent et al., "miR-133a enhances the protective capacity of cardiac progenitors cells afer myocardial infarction, " Stem Cell Reports, vol. 3, no. 6, pp. 1029-1042, 2014.